Table 4.
Outcome |
No. of studies | Pooled sample size |
Heterogeneity |
Overall effect |
|||
---|---|---|---|---|---|---|---|
T 2 | I 2 | P-value | SMD [95% CI] | P-value | |||
BMI |
4 |
605 |
0.05 |
65% |
0.03 |
0.21 [-0.06, 0.49] |
0.13 |
FPG |
8 |
1228 |
0.01 |
30% |
0.18 |
0.09 [-0.04, 0.23] |
0.18 |
HbA1c |
8 |
1228 |
0.03 |
56% |
0.03 |
0.06 [-0.12, 0.23] |
0.52 |
PPBS |
6 |
792 |
0.00 |
0% |
0.59 |
-0.01 [-0.15, 0.13] |
0.85 |
TC |
3 |
504 |
0.22 |
90% |
<0.0001 |
0.56 [0.00, 1.12] |
0.05 |
HDL |
3 |
504 |
0.18 |
88% |
0.0002 |
-0.27 [-0.78, 0.24] |
0.30 |
LDL |
3 |
504 |
0.01 |
21% |
0.28 |
0.41 [0.21, 0.61] |
<0.0001 |
TG |
3 |
504 |
0.00 |
0% |
0.61 |
0.13 [-0.05, 0.30] |
0.16 |
FINS | 5 | 698 | 0.44 | 93% | <0.00001 | 0.37 [-0.23, 0.98] | 0.22 |